510(k) Report

510(k) · Cleared

Cleared

AmeriWater MediQA Reverse Osmosis System (MSP3HF)

K223656510(k) SpecialCleared Feb 13, 202369-day reviewClass II21 CFR 876.5665

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

AmeriWater, LLC · FIP Subsystem, Water Purification

Cleared on Feb 13, 2023 as substantially equivalent to K131904 (Ameriwater, 2013) after a 69-day review. Its family tree reaches back 3 generations to 1994.

Decided
Feb 13, 2023
Review
69 days
Class
Class II
Product code
FIP
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K931595 (1994). No later device cites it as a predicate yet.

  1. Root · 3 generations backK931595 Reverse Osmosis Equipment for Water PurificationOsmonics, Inc. · 1994
  2. 2 generations backK974899 Gambro Central Water Treatment System CWP 100 - Wro HGambro Healthcare · 1998 · Recalled
  3. 1 generation backK131904 Mediqa Single Pass Reverse Osmosis System with Heat Sanitization…Ameriwater · 2013
  4. This deviceK223656 AmeriWater MediQA Reverse Osmosis System (MSP3HF)AmeriWater, LLC · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K931595Reverse Osmosis Equipment for Water PurificationOsmonics, Inc.1994—
−2K974899Gambro Central Water Treatment System CWP 100 - Wro HGambro Healthcare19982
−1K131904Mediqa Single Pass Reverse Osmosis System with Heat Sanitization, Mediqa…Ameriwater2013—
0 (this device)K223656AmeriWater MediQA Reverse Osmosis System (MSP3HF)AmeriWater, LLC2023—
FIG. 1 — Lineage of K223656, 1994–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FIP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FIP device

  1. #1 K251851 DIASAFEplusUS (F00013010)score 14.0 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K131904Mediqa Single Pass Reverse Osmosis System with Heat Sanitization, Mediqa Double Pass…
Summary page 4
…Page 1 of 5 January 31, 2023 510(K) SUMMARY Submission Type: Special 510(K): Device Modification - New Model Existing 510(K) Number: K131904 Submitter: AmeriWater, LLC Contact: Brian R. Bowman, Quality & EHS Manager…
Ameriwater2013—

Also cleared against K131904: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 4 companies; a new generation was cleared every 9.3 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • 1 other device also cites its predicate K131904.

How does its category compare?

All FIP devices

FIP Subsystem, Water Purification: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · FIP

4in 2025

2007: 12008: 32009: 32010: 22011: 42012: 22013: 42014: 42015: 22016: 22017: 12018: 12019: 22020: 12021: 12022: 12023: 32024: 12025: 4
2007high 4 (2011) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FIP

88in 2025

2008: 202 days median2009: 167 days median2011: 116 days median2013: 125 days median2014: 126 days median2023: 69 days median2025: 88 days median
2007high 202 (2008) · low 69 (2023)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FIP

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FIP

77in 2025

2007: 12008: 52010: 122011: 42012: 42013: 412014: 342015: 122016: 32017: 62018: 32019: 132020: 122021: 352022: 572023: 1402024: 1742025: 77
2007high 174 (2024) · low 0 (2009)2025

MAUDE reports naming product code FIP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
2008320205
2009316700
20102—012
2011411604
20122—04
20134125041
20144126034
20152—012
20162—03
20171—06
20181—03
20192—013
20201—112
20211—035
20221—057
20233690140
20241—0174
2025488077
20260—0—

What is it indicated for?

The AmeriWater MediQA Reverse Osmosis System is one component of a water treatment system designed to pre-treat and purify potable water using reverse osmosis for making dialysate for hemodialysis applications. The device is intended to be a component in a complete water purification system, and is not a complete water treatment system. It must be preceded by pretreatment devices, and may need to be followed by post-treatment devices as well to meet…

Read the full statement (266 words)

The AmeriWater MediQA Reverse Osmosis System is one component of a water treatment system designed to pre-treat and purify potable water using reverse osmosis for making dialysate for hemodialysis applications. The device is intended to be a component in a complete water purification system, and is not a complete water treatment system. It must be preceded by pretreatment devices, and may need to be followed by post-treatment devices as well to meet current AAMI and Federal (U.S.) standards. The AmeriWater MediQA is intended for use in water rooms in a hospital, clinic, or dialysis center. The device includes an integrated heat sanitization process.

The MediQA is available in both single pass and double pass models that supply from 4.5 to 16.0 gallons per minute (gpm) of product water. Model MSP1 is a single pass, single membrane RO that produces up to 5.0 gpm of product water. Model MSP2 is a single pass, dual-membrane RO that produces up to 9.4 gpm of product water. Model MSP3 is a single pass, 3-membrane RO that produces up to 12.6 gpm of product water. Model MSP3HF is a high-flow, single pass, 3-membrane RO that produces up to 16.0 gpm of product water. Model MDP1 is a double pass, 2-membrane RO that produces up to 5.0 gpm of product water. Model MDP2 is a double pass, 3-membrane RO that produces up to 7.0 gpm of product water. Model MDP3 is a double pass, 4-membrane RO that produces up to 10.0 gpm of product water. Model MDP4 is a double pass, 5-membrane RO that produces up to 12.0 gpm of product water.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K223656: AmeriWater MediQA Reverse Osmosis System (MSP3HF).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223656

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026